Innovations & Thérapeutiques en Oncologie
Volume 8, issue 4, July-August 2022
Volume 8, issue 4, July-August 2022
Éditorial/Editorial
Advanced practice registered nurse (APRN) in oncology: an innovation whose missions must be clear
(p.177-8)
Claude Linassier
Free Access
Humeur/Opinion Column
Covidiots and cancer: is there a single stupidity that THEY did not utter?
(p.179-81)
Jacques Robert, Fabrice Frank, Lonni Besançon, Alexander Samuel, Véronique Saada, Éric Billy, Barbara Seitz-Polski, Jérôme Barrière
Sélection et décryptage/Comments and Analysis
Comments and analysis
(p.182-92)
Patricia de Cremoux, Jacques Robert
Innovations acquises/Acquired Innovations
Estrogen receptor alpha (ESR1) gene mutations and hormone therapy resistance in luminal breast cancers: a 2022 update
(p.193-202)
Patricia De Cremoux, Marc Espié
Combining radiotherapy and targeted therapy to treat breast cancer
(p.203-10)
Arnaud Beddok, Paul Cottu, Alain Fourquet, Youlia Kirova
Innovation en cours/Ongoing Innovations
Exosomes: the secret messengers of cancer cells
(p.211-21)
Estefania Teixeira, Jessica Gobbo